Media Info
2020 Editorial Focus

2020 Editorial Focus

Here is where you can find the editorial focus for DDW in 2020:

WINTER 2019/20 - Automation

Biomarkers, AI, Screening, Precision Medicine, Proteomics, Informatics, ADME-Tox, Liquid Handling

SPRING 2020 - Oncology and Immunology

CRISPR, Immunotherapy, Gene Editing, Immuno-Oncology, RNAi, Antibodies, Mass Spectrometry,
T-Cell based tools

SUMMER 2020 - Target Identification and Validation

Toxicology, Next Gen Sequencing, Genomics, High Content Imaging, Epigenetics, Kinase Biology,
Fragment-Based Drug Design, Cell Therapy

FALL 2020 - Assay Development and Screening

Label-Free Assays, Stem Cells, Cell-Based Assays, High Throughput Screening, Microbiomics,
Drug Repurposing, Animal Models, Flow Cytometry


How DDW Source Editorial

Editorial is always sourced on the basis of DDW’s well known maxim of turning science into business. We commission articles from Pharma, Academia and the Technology Community that can talk candidly about the commercial potency of implementing new technologies and the impact these ultimately will have in discovering new drugs. We strive to keep the editorial balanced and objective and appeal to both camps, the scientist and, of course, the business leaders within the Pharma, Biotech and Academic Institutions.